AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| TCB | Ann:Suspension from Official Quotation - Failure to lodge Half Yearly Statements - 31 December 2017... | 21/03/18 | 0 | 98 | |||
|
|||||||
| TCB | Ann:Trading Halt - Failure to release Half Yearly Financial Statements - 31 December 2017 (Price... | 19/03/18 | 0 | 98 | |||
|
|||||||
See All Discussions
NSX News